Major histocompatibility complex, class II, DQ beta 1, also known as HLA-DQB1, is a human gene and also denotes the genetic locus that contains this gene.[5] The protein encoded by this gene is one of two proteins that are required to form the DQ heterodimer, a cell surface receptor essential to the function of the immune system.

HLA-DQB1
Available structures
PDBOrtholog search: PDBe RCSB
Identifiers
AliasesHLA-DQB1, CELIAC1, HLA-DQB, IDDM1, major histocompatibility complex, class II, DQ beta 1, HLA-DRB1
External IDsOMIM: 604305; MGI: 103070; HomoloGene: 1603; GeneCards: HLA-DQB1; OMA:HLA-DQB1 - orthologs
Orthologs
SpeciesHumanMouse
Entrez
Ensembl
UniProt
RefSeq (mRNA)

NM_002123
NM_001243961
NM_001243962

NM_207105

RefSeq (protein)

NP_001230890
NP_001230891
NP_002114

NP_996988

Location (UCSC)Chr 6: 32.66 – 32.67 MbChr 17: 34.48 – 34.49 Mb
PubMed search[3][4]
Wikidata
View/Edit HumanView/Edit Mouse

Function

edit

HLA-DQB1 belongs to the HLA class II beta chain paralogues. This class II molecule is a heterodimer consisting of an alpha (DQA) and a beta chain (DQB), both anchored in the membrane. It plays a central role in the immune system by presenting peptides derived from extracellular proteins. Class II molecules are expressed in antigen-presenting cells (APC: B lymphocytes, dendritic cells, macrophages).[5]

Gene structure and polymorphisms

edit

The beta chain is approximately 26-28 kDa and it contains 6 exons. Exon one encodes the leader peptide, exons 2 and 3 encode the two extracellular protein domains, exon 4 encodes the transmembrane domain, and exon 5 encodes the cytoplasmic tail. Within the DQ molecule, both the alpha chain and the beta chain contain the polymorphisms specifying the peptide binding specificities, resulting in up to 4 different molecules. Typing for these polymorphisms is routinely done for bone marrow transplantation.[5][6]

Disease association

edit

Autism

edit

A four-loci genotype study showed that A*01-B*07-DRB1*0701- DQB1*0602 (P = 0.001, OR 41.9) and the A*31-B*51-DRB1*0103- DQB1*0302 (P = 0.012, OR 4.8) are positively associated with autism among Saudi patients.

Diabetes

edit

Several alleles of HLA-DQB1 are associated with an increased risk of developing type 1 diabetes.[7][8][9] The locus also has the genetic name IDDM1 as it is the highest genetic risk for type 1 diabetes. Again the DQB1*0201 and DQB1*0302 alleles, particularly the phenotype DQB1*0201/*0302 has a high risk of late onset type 1 diabetes. The risk is partially shared with the HLA-DR locus (DR3 and DR4 serotypes).

Celiac disease

edit

Celiac1 is a genetic name for DQB1, the HLA DQB1*0201, *0202, and *0302 encode genes that mediate the autoimmune coeliac disease. Homozygotes of DQB1*0201 have a higher risk of developing the celiac disease, relative to any other genetic locus.[10]

Multiple sclerosis

edit

Certain HLA-DQB1 alleles are also linked to a modest increased risk of multiple sclerosis.[11][12]

Narcolepsy

edit

Other HLA-DQB1 alleles are associated with a predisposition to narcolepsy,[13] specifically HLA-DQB1*0602, which is carried by over 90% of patients with narcolepsy-cataplexy.[14]

Alleles

edit
HLA-DQB1 alleles
Serotype DQB1 allele
DQ2 *0201
*0202
*0203
DQ4 *0401
*0402
DQ5 *0501
*0502
*0503
*0504
DQ6 *0601
*0602
*0603
*0604
*0605
*0609
DQ7 *0301
*0304
DQ8 *0302
*0305
DQ9 *0303

See also

edit

References

edit
  1. ^ a b c ENSG00000206237, ENSG00000231286, ENSG00000206302, ENSG00000179344, ENSG00000231939, ENSG00000225824 GRCh38: Ensembl release 89: ENSG00000233209, ENSG00000206237, ENSG00000231286, ENSG00000206302, ENSG00000179344, ENSG00000231939, ENSG00000225824Ensembl, May 2017
  2. ^ a b c GRCm38: Ensembl release 89: ENSMUSG00000073421Ensembl, May 2017
  3. ^ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. ^ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  5. ^ a b c "Entrez Gene: HLA-DQB1 major histocompatibility complex, class II, DQ beta 1".
  6. ^ Lau M, Terasaki PI, Park MS (1994). "International Cell Exchange, 1994". Clinical Transplants: 467–88. PMID 7547576.
  7. ^ Todd JA (April 1990). "Genetic control of autoimmunity in type 1 diabetes". Immunology Today. 11 (4): 122–9. doi:10.1016/0167-5699(90)90049-F. PMID 2187469.
  8. ^ Todd JA (March 1997). "Genetics of type 1 diabetes". Pathologie-Biologie. 45 (3): 219–27. PMID 9296067.
  9. ^ Redondo MJ, Fain PR, Eisenbarth GS (2001). "Genetics of type 1A diabetes". Recent Progress in Hormone Research. 56: 69–89. doi:10.1210/rp.56.1.69. PMID 11237226.
  10. ^ Murray JA, Moore SB, Van Dyke CT, Lahr BD, Dierkhising RA, Zinsmeister AR, Melton LJ, Kroning CM, El-Yousseff M, Czaja AJ (December 2007). "HLA DQ gene dosage and risk and severity of celiac disease". Clinical Gastroenterology and Hepatology. 5 (12): 1406–12. doi:10.1016/j.cgh.2007.08.013. PMC 2175211. PMID 17919990.
  11. ^ Dyment DA, Sadovnick AD, Ebers GC, Sadnovich AD (1997). "Genetics of multiple sclerosis". Human Molecular Genetics. 6 (10): 1693–8. doi:10.1093/hmg/6.10.1693. PMID 9300661.
  12. ^ Schmidt H, Williamson D, Ashley-Koch A (May 2007). "HLA-DR15 haplotype and multiple sclerosis: a HuGE review". American Journal of Epidemiology. 165 (10): 1097–109. doi:10.1093/aje/kwk118. PMID 17329717.
  13. ^ Kadotani H, Faraco J, Mignot E (May 1998). "Genetic studies in the sleep disorder narcolepsy". Genome Research. 8 (5): 427–34. doi:10.1101/gr.8.5.427. PMID 9582188.
  14. ^ "Narcolepsy Research - FAQs".
edit
  • Overview of all the structural information available in the PDB for UniProt: P01920 (HLA class II histocompatibility antigen, DQ beta 1 chain) at the PDBe-KB.